))
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape. Welcome to Talk Radioisotopes: Going Nuclear on Cancer. We’ll take a look at the latest insights, trends and developments working to change patient outcomes and supply the fight against cancer ...
…
continue reading
1
Shamar Young, Chief Medical Officer at TeleDaaS
31:38
31:38
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
31:38
On this episode of Talk Radioisotopes, Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explores Dr. Young’s journey into interventional radiology, his expertise in Yttrium-90 (Y90) therapy, and the evolving role of precision…
…
continue reading
1
Bruno Paquin, CEO of AtomVie Global Radiopharma
40:57
40:57
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
40:57
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma. Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract development and manufacturing organization (CDMO), their cutting-edge work in ca…
…
continue reading
1
Arjun Murthy, Co-Founder of Maven Bio
31:51
31:51
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
31:51
On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun's background, along with Maven Bio's technology, is transforming data analysis and research in the biopharma sector. Key topics include how AI is a…
…
continue reading
1
Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals
45:17
45:17
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
45:17
On this episode, hosts Scott and Sarah sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus's journey through the radiopharmaceutical industry, Clarity's innovations, and breakthroughs involving copper-based compounds for cancer treatment. Shaemus shares insights on the importance of …
…
continue reading
1
Jeff Jones, Managing Director, Senior Analyst at Oppenheimer & Company
36:37
36:37
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
36:37
On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,' host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company. The discussion covers the latest trends in the radiopharmaceutical and radiotherapeutics markets, including the rise of targeted radiotherapies, the involvement of large pha…
…
continue reading
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape. Welcome to Talk Radioisotopes: Going Nuclear o…
…
continue reading
